ChoA Pharmaceutical Co.Ltd Capital Reinvestment Ratio

Latest as of September 2025: 0.26x

ChoA Pharmaceutical Co.Ltd capital reinvestment ratio. ChoA Pharmaceutical Co.Ltd (034940) has a Capital Reinvestment Ratio of 0.26x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.26 Billion) in capital expenditures (₩324.67 Million). Check total reinvestment intensity of ChoA Pharmaceutical Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.26x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.26 Billion
KRW

Capital Expenditures

₩324.67 Million
KRW

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of ChoA Pharmaceutical Co.Ltd (2004–2020)

Capital reinvestment ratio of ChoA Pharmaceutical Co.Ltd from 2004 to 2020. This chart tracks ChoA Pharmaceutical Co.Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore 034940 net asset momentum to track the company's year-over-year net asset growth rate.

ChoA Pharmaceutical Co.Ltd Capital Reinvestment Ratio by Year (2004–2020)

ChoA Pharmaceutical Co.Ltd capital reinvestment ratio by year from 2004 to 2020. For the full cash flow conversion analysis, see ChoA Pharmaceutical Co.Ltd cash conversion from operations.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2020 1.87x ₩1.92 Billion ₩3.60 Billion ▲ +460.2%
2019 0.33x ₩4.16 Billion ₩1.39 Billion ▼ -65.4%
2018 0.96x ₩2.04 Billion ₩1.97 Billion ▼ -60.9%
2016 2.47x ₩930.42 Million ₩2.30 Billion ▲ +64.4%
2015 1.50x ₩1.19 Billion ₩1.78 Billion ▼ -83.3%
2014 9.02x ₩625.52 Million ₩5.64 Billion ▲ +2884.8%
2013 0.30x ₩3.53 Billion ₩1.07 Billion ▲ +110.8%
2004 0.14x ₩3.57 Billion ₩512.47 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow